EIA Kits
Please use the dropdown below to find out about EIA Kits available outside the
United States:
CanAg CA19-9 EIA - Gastrointestinal Cancer
The CanAg CA19-9 EIA is based on a mouse monoclonal antibody, C192, highly specific for the sialyl Lewisa epitope, also known as CA19-9 antigen1.
In adults, the epitope is typically expressed in trace amounts on mucosal cells of gastrointestinal epithelia. In patients with malignant disease, the epitope may appear associated with high molecular weight mucin in blood. Assays for CA19-9 are frequently used to monitor gastrointestinal malignancies such as pancreatic, gall bladder, gastric, and colorectal cancers2, 3.
Download our CanAg CA19-9 product information:
Product Catalog
CANAG CA19-9 EIA - FULL PACKAGE INSERT
CANAG CA19-9 EIA - MATERIAL SAFETY DATA SHEET
Product no: 200-10 (Not for distribution in the United States)
References
- Rye P. D. et al., (1998) Summary report on the ISOBM TD-6 workshop: Analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreaux, Switzerland; September 19-24 1997. Tumor Biol. 19:390-420.
- Eskelinen M., and Haglund U. (1999) Developments in serologic detection of human pancreatic adenocarcinoma. Scand J Gastroenterol. 34: 833-844.
- Hammarström S., and Stigbrand T. (2002) Gastric Cancer. In “Tumor markers, Physiology, Pathobiology, Technology and Clinical Applications” Eds. Diamandis E. P. et al., AACC Press, Washington pp 375-379.